Rice Hall James & Associates’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,416
Closed -$302K 281
2022
Q1
$302K Sell
4,416
-14
-0.3% -$997 0.01% 274
2021
Q4
$350K Hold
4,430
0.01% 273
2021
Q3
$350K Hold
4,430
0.01% 271
2021
Q2
$349K Hold
4,430
0.01% 272
2021
Q1
$334K Buy
4,430
+225
+5% +$16.5K 0.01% 272
2020
Q4
$277K Hold
4,205
0.01% 275
2020
Q3
$227K Buy
+4,205
New +$231K 0.01% 260

Other funds holding ENOV

Rice Hall James & Associates's ENOV Position: Q2 2022 in Review

Rice Hall James & Associates sold out of Enovis (ENOV) in Q2 2022, closing a stake of 4,416 shares — an estimated $302K sold.

Rice Hall James & Associates first reported a position in ENOV in Q3 2020 and held it in 7 quarters. The position peaked at $350K in Q4 2021. 245 funds tracked by Wall St. Rank hold ENOV as of Q2 2022.

  • Rice Hall James & Associates reported no remaining Enovis position as of Q2 2022 after selling out during the quarter.
  • Rice Hall James & Associates sold 4,416 Enovis shares in Q2 2022, an estimated $302K.
  • Rice Hall James & Associates first reported a position in Enovis in Q3 2020 and held it in 7 quarters.
  • Rice Hall James & Associates's Enovis position peaked at $350K in Q4 2021.
  • 245 funds tracked by Wall St. Rank held Enovis as of Q2 2022.

Based on Rice Hall James & Associates's 13F filing for Q2 2022, filed 8 Aug 2022.